Liryc is a research, treatment, innovation and teaching institute, wholly dedicated to the study, diagnosis and treatment of cardiac electrical disorders. These electrical disorders are responsible for various cardiovascular diseases and sudden deaths, and cause -directly or indirectly- around one third of all deaths in the world.
The strength of Liryc is the breadth and depth its scientific expertise, and its close association with internationally recognized clinical teams and information technology/modelling laboratories already based in Bordeaux.
Liryc constitutes a medical and scientific multidisciplinary program dedicated to the understanding of cardiac electrical dysfunctions. It addresses the most prevalent arrhythmia and main risk factors for embolic stroke: atrial fibrillation (the most lethal cardiac rhythm disorder), ventricular fibrillation and electrical ventricular dyssynchrony (leading to heart failure).